Content Syndication Downloads Lensar
New Data Supports Benefits of FLACS for Premium Patients
Data using the LENSAR®’S ALLY® Adaptive Cataract Treatment System confirms that FLACS is an excellent procedure, especially with premium patients. This next-generation femto enhances the laser-assisted procedure with reduced ultrasound energy to the eye with less endothelial cell loss, faster procedure times, precise and repeatable capsulorhexis and incisions, and superior astigmatism management with the opportunity for immediate patient benefit.
Read more about the latest FLACS advancements that could guide you to deliver better patient outcomes and grow your premium practice.
Sponsored By
Advertisement
Recommendations
Advertisement